Literature DB >> 6132413

Rebound insomnia and rebound anxiety: a review.

A Kales, C R Soldatos, E O Bixler, J D Kales.   

Abstract

Rebound insomnia and rebound anxiety are clinical conditions related to withdrawal of certain benzodiazepine drugs. Numerous studies of benzodiazepine and nonbenzodiazepine hypnotics conducted in our sleep laboratory demonstrated that rebound insomnia developed following withdrawal from benzodiazepines with a rapid or intermediate elimination rate. Several studies conducted by other investigators also indicated the development of rebound insomnia under similar conditions. Rebound insomnia and rebound anxiety are discussed in terms of their interrelationship, clinical implications, and receptor mechanisms. Evidence suggests that drugs producing rebound insomnia and rebound anxiety also show a more rapid development of tolerance and greater potential for drug dependence than benzodiazepines where the parent compound or its metabolites have a long elimination half-life.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132413     DOI: 10.1159/000137794

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  26 in total

1.  Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.

Authors:  T Roehrs; L Merlotti; F Zorick; T Roth
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Dose determinants of rebound insomnia.

Authors:  T A Roehrs; F J Zorick; R M Wittig; T Roth
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

4.  A practical guide to prescribing hypnotic benzodiazepines.

Authors:  M Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

Review 5.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  The dependence potential of short half-life benzodiazepines: a meta-analysis.

Authors:  D D Hallfors; L Saxe
Journal:  Am J Public Health       Date:  1993-09       Impact factor: 9.308

7.  Prevalence and treatment of insomnia in general practice. A longitudinal study.

Authors:  F Hohagen; K Rink; C Käppler; E Schramm; D Riemann; S Weyerer; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 8.  Rebound insomnia and newer hypnotics.

Authors:  M Lader
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

10.  Effects of brotizolam on the sleep of chronic insomniacs.

Authors:  M Mamelak; A Csima; V Price
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.